Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceuticals targeting cancer. Its structure enables selective binding to enzyme active sites, making it valuable in developing drugs for leukemia and other malignancies. Also employed in research for designing novel antiviral agents due to its ability to mimic purine bases. Commonly modified at the carboxylic acid group to enhance bioavailability and potency in final drug compounds.